Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Epilepsy

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1609600

Analysis of Clinical Features and Genetic Variants in Chinese Children With Pyridoxine-Dependent Epilepsy: A Case Series Study

Provisionally accepted
Xixi  YuXixi Yu1Xin  ZhangXin Zhang2Shiyan  QiuShiyan Qiu2Li  YangLi Yang2*Xin  LiXin Li1Dongyu  ShiDongyu Shi1
  • 1Shandong Second Medical University, Weifang, China
  • 2Linyi People's Hospital, Linyi, Shandong Province, China

The final, formatted version of the article will be published soon.

To summarize the clinical features and the spectrum of ALDH7A1 gene variants in Chinese children with pyridoxine-dependent epilepsy (PDE).METHODS: Clinical data were collected from six pediatric patients with PDE treated at Linyi People 's Hospital (2017-2023). Whole-exome sequencing, in conjunction with Sanger sequencing, was used to screen for ALDH7A1 gene variant sites. Bioinformatics methods were applied in combination with clinical phenotype assessment to evaluate the pathogenicity of the variants.In six cases of PDE, the male-to-female ratio was 2:4. Five cases began in the neonatal period, and one in early infancy. Three cases experienced hypoxiaetal distress or respiratory distress. Two cases had a family history of recurrent miscarriages or premature deaths of siblings due to seizures. Seizure types varied among the cases. Three individuals experienced cluster seizures, two were heat-sensitive, and four suffered from status epilepticus. Video EEGs of four children revealed hypsarrhythmia, focal, or multifocal discharges initially, which normalized within 3 days to 8 months following vitamin B6 treatment. All patients initiated regular vitamin B6 therapy between 32 days and 17 months post-onset, with an initial dose ranging from 7.7 to 12.5 mg/(kg•d). During follow-up until the age of 1 to 8 years, the maintenance dose was adjusted to 3.3 to 7.8 mg/(kg•d). Two patients who began standardized treatment before the age of 3 months experienced normal development. The remaining patients showed mild to moderate developmental delays. Eight variants were identified, including a hotspot in Chinese children: c.1008+1G>A, and two recurrent sites: c.1061A>G and c.1547A>G. Additionally, three variants were novel. CONCLUSION: PDE must be distinguished from hypoxic-ischemic encephalopathy and other thermally sensitive epilepsies. The severity of the condition and neurodevelopmental outcomes in affected children vary significantly. Early administration of low-dose pyridoxine can effectively control seizures and reverse EEG abnormalities, potentially improving long-term neurodevelopmental outcomes. c.1061A>G and c.1547A>G may be hotspot variants in Chinese children with PDE.

Keywords: Pyridoxine, Epilepsy, Child, Mutation, ALDH7A1 gene

Received: 05 Jun 2025; Accepted: 07 Aug 2025.

Copyright: © 2025 Yu, Zhang, Qiu, Yang, Li and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Li Yang, Linyi People's Hospital, Linyi, Shandong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.